• 呈黄绿色肝细胞

    Here is another hepatocellular carcinoma with a greenish yellow hue.

    youdao

  • 方法回顾分析26病理证实肝细胞ct资料

    Methods Review and analysis of 26 cases of hepatocellular carcinoma with CT information were confirmed through pathology.

    youdao

  • 方法回顾分析26病理证实肝细胞ct资料

    Review and analysis of 26 cases of hepatocellular carcinoma with CT information were confirmed through pathology.

    youdao

  • 这个百分比中,造成肝细胞53%,是25%。

    Of this percentage, hepatocellular carcinoma was caused by Hep B in 53%, and Hep C in 25%.

    youdao

  • 分析伴有横纹肌肉瘤成分肝细胞临床病理组织学特征

    Objective to analyze the clinical and pathologic features of hepatocellular carcinoma with rhabdomyosarcoma component.

    youdao

  • 中国远东超过80%肝细胞癌患者慢性病毒感染

    In parts of China and the Far East, over 80% of HCC patients have chronic HBV infection.

    youdao

  • 方法运用透射电镜观察经顺化疗后缩小切除细胞癌形态学特征改变

    Methods The changes of morphological feature of HCC treated by diam- minedichloroplatinum were observed with transmission electron microscope.

    youdao

  • 背景移植其它方法不可治疗细胞HCC一个公认治疗方法

    BACKGROUND: Liver transplantation is an accepted treatment option for patients with otherwise untreatable hepatocellular carcinoma (HCC).

    youdao

  • 分析33手术病理证实细胞术前mri边缘形态24标本MRI与病理基础对照研究

    Method Tumor border patterns on MRI of 33 cases of HCC were analyzed, and MRI pathologic correlation study of 24 resected HCC specimens were performed.

    youdao

  • 由于缺乏预测进展复发肿瘤标志物那些有可能被治疗更高阶段细胞癌患者拒绝用移植疗法。

    Potentially curable higher-stage HCC patients are denied LT due to the lack of cancer markers that predict progression and recurrence.

    youdao

  • 探讨动脉灌注32玻璃微球( 32PGMS核素内照射治疗手术不能切除肝细胞疗效

    Objective To investigate the efficacy of internal radiation of 32 P glass microspheres( 32 P GMS) in unresected hepatocellular carcinoma(HCC) via subcutaneous arterial port.

    youdao

  • 方法回顾性分析3肝细胞接受移植病人临床资料

    Methods The clinical data of 3 patients with hepatocellular carcinoma receiving orthotopic liver transplantation were analyzed.

    youdao

  • 国际细胞大多数特征可以通过遗传表观遗传改变来解释谈谈关于肝细胞(HCC)最新进展吗?

    International Digest: Most features of the cancer cell can be explained by genetic or epigenetic changes. Can you talk about the latest progress in terms of hepatocellular carcinoma (HCC)?

    youdao

  • 分析原发性肝细胞(HCC)自发性破裂出血病理基础CT特点

    Objective to analyze the pathologic basis and ct features of spontaneous rupture in hepatocellular carcinoma (HCC).

    youdao

  • 肝细胞(HCC)常见恶性肿瘤之一由于快速浸润性生长合并硬化因此其预后不良

    Hepatocellular carcinoma (HCC) is one of the most common malignancies. It has a poor prognosis due to its rapid infiltrating growth and complicated liver cirrhosis.

    youdao

  • 肝细胞癌原发性

    HCC is a primary cancer of the liver.

    youdao

  • 本文肝细胞蛋白质组学研究进展简要综述。

    In this paper we reviewed the recent progress in proteomic study of hepatocellular carcinoma.

    youdao

  • 联合这些分子标志物帮助提高器官HCV -肝细胞癌患者分配

    Incorporation of these molecular markers could help to improve organ allocation for HCV-HCC patients.

    youdao

  • 研究结果显示三个因素NASH相关性硬化细胞癌发生存在统计学意义

    Results indicate three factors that are statistically significant in the development of HCC within the NASH-cirrhosis group.

    youdao

  • 结果令人鼓舞因为最初治疗之后细胞癌反应早期看法是必要以便改善预后指导今后治疗。

    This result is encouraging because early knowledge of HCC response after initial therapy is essential to revise prognosis and guide future therapy.

    youdao

  • 尽管移植治疗肝细胞确认疗法目前为首次治疗运用切除术病人提供移植术。

    But although liver transplantation is a recognized therapy for hepatocellular carcinoma, it is not currently offered to those who undergo hepatic resection as the first-line therapy, he notes.

    youdao

  • 分析细胞癌低场MR征象。

    Objective:To study the features of HCC on low-field MR.

    youdao

  • 探讨低场MR肝细胞(HCC)诊断鉴别诊断中价值

    To evaluate the diagnosis and differential diagnosis value of low-field MR plain scanning in hepatocellular carcinoma (HCC) and hemangioma.

    youdao

  • 根据目前通用临床分类可以把肝细胞癌患者分成5,每期都有一个特定针对治疗方案

    The current clinical classification of HCC divides patients into 5 stages with a specific treatment-oriented schedule.

    youdao

  • 世界肝细胞第五常见死亡第三主要原因

    Hepatocellular carcinoma, HCC, or liver cancer, is the fifth most common cancer and the third leading cause of cancer deaths in the world.

    youdao

  • 探讨硬变细胞不典型增生(L CD)细胞(HCC)关系

    Objective: to study the relationship between liver cirrhosis, liver cell dysplasia (LCD) and hepatocellular carcinoma (HCC).

    youdao

  • 研究带蒂细胞(phc)诊断治疗

    PURPOSE to study the diagnosis and treatment of pedunculated hepatocellular carcinoma (PHC).

    youdao

  • 研究带蒂细胞(phc)诊断治疗

    PURPOSE to study the diagnosis and treatment of pedunculated hepatocellular carcinoma (PHC).

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定